In contrast, the splenic injection model using KPCPb–/– mouse PDAC cells with shRNA knockdown of the vimentin gene showed a reduced metastatic tumor burden compared with KPCPb–/– mouse PDAC cells with control shRNA (Figure 7, D and E). The gene discussed is VIM; the disease is neoplasm.